Malus domestica fruit-derived vesicles extract protect against upstream cellular hallmarks of vascular inflammation and epithelial barrier dysfunction

Background Dysbiosis impairs the intestinal barrier, facilitating the systemic translocation of inflammatory molecules into the bloodstream and ultimately contributing to cardiovascular disease. In this study, apple-derived extracellular vesicles (ADEVs) were evaluated as natural carriers of immunomodulatory signals to non-invasively restore immune homeostasis while preventing vascular inflammation and epithelial barrier dysfunction. Methods ADEVs were isolated from Malus domestica via tangential flow filtration and characterized by particle concentration, size distribution, and total protein content. Vesicle integrity and cargo stability were evaluated across multiple storage temperature assays. The immunomodulatory effects of ADEVs against lipopolysaccharide-induced inflammation were assessed in both in vitro human cell lines and an in vivo mouse model. Results ADEVs isolated by this scalable purification method, maintained structural integrity, concentration, and size uniformity following cryopreservation. Functional assays revealed that ADEVs significantly fortified the intestinal epithelial barrier, suppressed pro-inflammatory signaling, and prevented endothelial activation, effectively blocking key mechanisms of monocyte recruitment. In the murine model, ADEVs were safely metabolized within hours without accumulation in major organs. Crucially, ADEVs induced a dual polarization of immune cells toward both pro-resolving and functional states, successfully recalibrating systemic immune homeostasis. Conclusion ADEVs function as highly efficient, biocompatible carriers of natural regulatory signals that mitigate inflammation responses. By simultaneously reinforcing the intestine barrier and modulating immune activity, ADEVs represent a viable, minimally invasive therapeutic strategy against the upstream cellular drivers of vascular inflammation and epithelial dysfunction.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-06
DOI
https://doi.org/10.3389/fphar.2026.1911938
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Malus domestica fruit-derived vesicles extract protect against upstream cellular hallmarks of vascular inflammation and epithelial barrier dysfunction

Luca Lovatti, Laura A. Basile, Barbara Zavan, Letizia Ferroni et al.
3 links
Frontiers in Pharmacology
Extracellular vesicles in disease
article

Malus domestica fruit-derived vesicles extract protect against upstream cellular hallmarks of vascular inflammation and epithelial barrier dysfunction

Luca Lovatti, Laura A. Basile, Barbara Zavan, Letizia Ferroni, Leo Massari, Paolo Pinton, Sonia Missiroli, Marta Degasperi, Jasmine Chini, Ilenia Pia Cappucci, Lucia Sileo, Maria Pia Cavaleri, Luna Ardondi, Ilaria Vitali
article en

Abstract

Background Dysbiosis impairs the intestinal barrier, facilitating the systemic translocation of inflammatory molecules into the bloodstream and ultimately contributing to cardiovascular disease. In this study, apple-derived extracellular vesicles (ADEVs) were evaluated as natural carriers of immunomodulatory signals to non-invasively restore immune homeostasis while preventing vascular inflammation and epithelial barrier dysfunction. Methods ADEVs were isolated from Malus domestica via tangential flow filtration and characterized by particle concentration, size distribution, and total protein content. Vesicle integrity and cargo stability were evaluated across multiple storage temperature assays. The immunomodulatory effects of ADEVs against lipopolysaccharide-induced inflammation were assessed in both in vitro human cell lines and an in vivo mouse model. Results ADEVs isolated by this scalable purification method, maintained structural integrity, concentration, and size uniformity following cryopreservation. Functional assays revealed that ADEVs significantly fortified the intestinal epithelial barrier, suppressed pro-inflammatory signaling, and prevented endothelial activation, effectively blocking key mechanisms of monocyte recruitment. In the murine model, ADEVs were safely metabolized within hours without accumulation in major organs. Crucially, ADEVs induced a dual polarization of immune cells toward both pro-resolving and functional states, successfully recalibrating systemic immune homeostasis. Conclusion ADEVs function as highly efficient, biocompatible carriers of natural regulatory signals that mitigate inflammation responses. By simultaneously reinforcing the intestine barrier and modulating immune activity, ADEVs represent a viable, minimally invasive therapeutic strategy against the upstream cellular drivers of vascular inflammation and epithelial dysfunction.

Frontiers in PharmacologyVol. 17
University of Ferrara (IT), Maria Cecilia Hospital (IT), Consorzio Melinda Sca (Italy) (IT)
Good health and well-being
Openalex Percentile: Top 27%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon